SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-03-001293
Filing Date
2003-04-11
Accepted
2003-04-11 14:18:09
Documents
5
Period of Report
2003-05-13
Effectiveness Date
2003-04-11

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS, INC.DEFINITIVE PROXY w84735def14a.htm DEF 14A 237078
3 GRAPHIC w84735guiphal1.gif GRAPHIC 7518
4 GRAPHIC w84735crsmith1.gif GRAPHIC 5236
5 GRAPHIC w84735ashrubs1.gif GRAPHIC 4286
6 GRAPHIC w84735w8473501.gif GRAPHIC 10284
  Complete submission text file 0000950133-03-001293.txt   266304
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23736 | Film No.: 03646862
SIC: 2834 Pharmaceutical Preparations